Beyond statins: New pharmacological targets to decrease LDL-cholesterol and cardiovascular events
Emanuel Raschi, Manuela Casula, Arrigo F.G. Cicero, Alberto Corsini, Claudio Borghi, Alberico L. Catapano
Topics & Concepts
AlirocumabEzetimibeEvolocumabPCSK9MedicineDyslipidemiaMicrosomal triglyceride transfer proteinProprotein convertaseStatinKexinPharmacologyFamilial hypercholesterolemiaInternal medicineBioinformaticsCholesterolLipoproteinLDL receptorDiseaseVery low-density lipoproteinBiologyApolipoprotein A1Lipoproteins and Cardiovascular HealthAtherosclerosis and Cardiovascular DiseasesHealth Systems, Economic Evaluations, Quality of Life